Siren Biotechnology
Universal AAV immuno-gene therapy for cancer
9 employees · est. 2020 · San Francisco, United States
Deka Biosciences, Inc is the older company (2018 vs 2020); Deka Biosciences, Inc is the larger of the two.
Side-by-Side Comparison
| Metric | Deka Biosciences, Inc | Siren Biotechnology |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2020 |
| Headquarters | ||
| Headquarters | Germantown, United States | San Francisco, United States |
| Employees | ||
| Employees | 40 larger | 9 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series Unknown | Seed |
| Total Funding | ||
| Total Funding | $91.35M | $23.60M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Development of universal AAV immuno-gene therapy, Combination of AAV gene therapy and cytokine immunotherapy |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer patients, Medical professionals, Healthcare providers, Oncologists |
| Taxonomy | ||
| Taxonomy | Cancer Therapy, Inflammatory Diseases, Cytokine Therapy, IL-10 Variants, ScFv Technology, Targeted Therapies, Biotech Startup, Immunotherapy, Cancer Treatment | Universal AAV Immuno-Gene Therapy, Cancer Treatment, Gene Therapy, Cytokine Immunotherapy, Tumor Cell Destruction, Anti-tumor Immunity, Immunotherapy, Oncology, Medical Innovation |
| Website | ||
| Website | dekabiosciences.com | sirenbiotechnology.com |
About Deka Biosciences, Inc
Deka Biosciences, Inc. is an early-stage biotechnology company founded in 2018 and headquartered in the United States. The company is focused on developing the next generation of targeted cytokine therapies to treat cancer and inflammatory diseases. Their innovative DiakineTM platform consists of op...
About Siren Biotechnology
Siren Biotechnology, founded in 2020, is a pioneering company situated in the expansive field of Biotechnology. Headquartered in the United States, the company has taken a bold step in the fight against cancer with its innovative approach: Universal AAV Immuno-Gene Therapy. The company uniquely int...
We will tell you when either one moves
BounceWatch watches Deka Biosciences, Inc and Siren Biotechnology for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Deka Biosciences, Inc and Siren Biotechnology — by email.
Frequently Asked Questions
Compare Deka Biosciences, Inc with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Deka Biosciences, Inc on 12 Sep 2024, and Siren Biotechnology on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
